Exploiting pre-existing viral immunity for B cell vaccination against endogenous antigens
<p>Cancer vaccines are a novel method of treating cancer by harnessing the patient’s own immune system to recognise and attack malignant cells. Viral vectors can be used to encode tumour antigens to be presented to the immune system. However this field is hindered by immunity to the viral vect...
| Autor Principal: | |
|---|---|
| Outros autores: | |
| Formato: | Thesis |
| Idioma: | English |
| Publicado: |
2013
|
| Subjects: |